Cargando…

Peripheral mitochondrial function correlates with clinical severity in idiopathic Parkinson's disease

BACKGROUND: Parkinson's disease is an intractable disorder with heterogeneous clinical presentation that may reflect different underlying pathogenic mechanisms. Surrogate indicators of pathogenic processes correlating with clinical measures may assist in better patient stratification. Mitochond...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milanese, Chiara, Payán‐Gómez, César, Galvani, Marta, Molano González, Nicolás, Tresini, Maria, Nait Abdellah, Soraya, van Roon‐Mom, Willeke M. C., Figini, Silvia, Marinus, Johan, van Hilten, Jacobus J., Mastroberardino, Pier G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771759/ https://www.ncbi.nlm.nih.gov/pubmed/31136028 http://dx.doi.org/10.1002/mds.27723

Ejemplares similares

Associated and predictive factors of depressive symptoms in patients with Parkinson’s disease
por: Zhu, Kangdi, et al.
Publicado: (2016)

Assessing Walking Adaptability in Parkinson's Disease: “The Interactive Walkway”
por: Geerse, Daphne J., et al.
Publicado: (2018)

Oral Health of Parkinson's Disease Patients: A Case-Control Study
por: van Stiphout, Marjolein A. E., et al.
Publicado: (2018)

Loss of integrity and atrophy in cingulate structural covariance networks in Parkinson's disease
por: de Schipper, Laura J., et al.
Publicado: (2017)

Bioenergetics in fibroblasts of patients with Huntington disease are associated with age at onset
por: Gardiner, Sarah L., et al.
Publicado: (2018)

Altered Whole-Brain and Network-Based Functional Connectivity in Parkinson's Disease
por: de Schipper, Laura J., et al.
Publicado: (2018)

Regional Structural Hippocampal Differences Between Dementia with Lewy Bodies and Parkinson’s Disease
por: de Schipper, Laura J., et al.
Publicado: (2019)

The MID1 Protein: A Promising Therapeutic Target in Huntington’s Disease
por: Heinz, Annika, et al.
Publicado: (2021)

Increased sensitivity of next generation sequencing-based expression profiling after globin reduction in human blood RNA
por: Mastrokolias, Anastasios, et al.
Publicado: (2012)

Ataxin-3 Protein and RNA Toxicity in Spinocerebellar Ataxia Type 3: Current Insights and Emerging Therapeutic Strategies
por: Evers, Melvin M., et al.
Publicado: (2013)

Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice
por: Toonen, Lodewijk J.A., et al.
Publicado: (2017)

Juvenile‐Onset Huntington Disease Pathophysiology and Neurodevelopment: A Review
por: Bakels, Hannah S., et al.
Publicado: (2021)

Antisense oligonucleotide-mediated exon skipping as a strategy to reduce proteolytic cleavage of ataxin-3
por: Toonen, Lodewijk J. A., et al.
Publicado: (2016)

Holocue: A Wearable Holographic Cueing Application for Alleviating Freezing of Gait in Parkinson's Disease
por: Geerse, Daphne J., et al.
Publicado: (2022)

Cost-effective HRMA pre-sequence typing of clone libraries; application to phage display selection
por: Pepers, Barry A, et al.
Publicado: (2009)

Targeting the Gut–Brain Axis with Fecal Microbiota Transplantation: Considerations on a Potential Novel Treatment for Parkinson's Disease
por: Contarino, Maria Fiorella, et al.
Publicado: (2022)

Inefficient DNA Repair Is an Aging-Related Modifier of Parkinson’s Disease
por: Sepe, Sara, et al.
Publicado: (2016)

Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias
por: Buijsen, Ronald A.M., et al.
Publicado: (2019)

Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral blood
por: Mastrokolias, Anastasios, et al.
Publicado: (2015)

Spreading of complex regional pain syndrome: not a random process
por: van Rijn, Monique A., et al.
Publicado: (2011)

Osteopontin and phospho‐SMAD2/3 are associated with calcification of vessels in D‐CAA, an hereditary cerebral amyloid angiopathy
por: Grand Moursel, Laure, et al.
Publicado: (2019)

Thermal hypesthesia in patients with complex regional pain syndrome related dystonia
por: Munts, Alexander G., et al.
Publicado: (2010)

Antisense-Mediated RNA Targeting: Versatile and Expedient Genetic Manipulation in the Brain
por: Zalachoras, Ioannis, et al.
Publicado: (2011)

Therapeutic Strategies for Spinocerebellar Ataxia Type 1
por: Kerkhof, Laurie M. C., et al.
Publicado: (2023)

Transcriptomic Signatures Associated With Regional Cortical Thickness Changes in Parkinson’s Disease
por: Keo, Arlin, et al.
Publicado: (2021)

Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington's disease
por: van Roon-Mom, Willeke MC, et al.
Publicado: (2008)

Statistical method for modeling sequencing data from different technologies in longitudinal studies with application to Huntington disease
por: Fuady, Angga M., et al.
Publicado: (2020)

Preparing n-of-1 Antisense Oligonucleotide Treatments for Rare Neurological Diseases in Europe: Genetic, Regulatory, and Ethical Perspectives
por: Synofzik, Matthis, et al.
Publicado: (2022)

Human Induced Pluripotent Stem Cell-Based Modelling of Spinocerebellar Ataxias
por: Hommersom, Marina P., et al.
Publicado: (2021)

Post‐mortem 7T MR imaging and neuropathology in middle stage juvenile‐onset Huntington disease: A case report
por: Bakels, Hannah S., et al.
Publicado: (2022)

Experience in Genetic Counseling for GBA1 Variants in Parkinson's Disease
por: den Heijer, Jonas M., et al.
Publicado: (2020)

Sex matters in complex regional pain syndrome
por: van Velzen, Gijsbrecht A. J., et al.
Publicado: (2019)

Exploring the Transcriptome of Ciliated Cells Using In Silico Dissection of Human Tissues
por: Ivliev, Alexander E., et al.
Publicado: (2012)

Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington’s disease peripheral blood samples
por: Mastrokolias, Anastasios, et al.
Publicado: (2016)

Predicting Motor Outcome and Quality of Life After Subthalamic Deep Brain Stimulation for Parkinson’s Disease: The Role of Standard Screening Measures and Wearable-Data
por: Geraedts, Victor J., et al.
Publicado: (2023)

Pathological characterization of T2*-weighted MRI contrast in the striatum of Huntington’s disease patients
por: Bulk, Marjolein, et al.
Publicado: (2020)

Iron accumulation induces oxidative stress, while depressing inflammatory polarization in human iPSC-derived microglia
por: Kenkhuis, Boyd, et al.
Publicado: (2022)

Common disease signatures from gene expression analysis in Huntington’s disease human blood and brain
por: Mina, Eleni, et al.
Publicado: (2016)

Intracerebroventricular Administration of a 2′-O-Methyl Phosphorothioate Antisense Oligonucleotide Results in Activation of the Innate Immune System in Mouse Brain
por: Toonen, Lodewijk J.A., et al.
Publicado: (2018)

Fixed Dystonia in Complex Regional Pain Syndrome: a Descriptive and Computational Modeling Approach
por: Munts, Alexander G, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_lvh2v237eeg4t8795r933l5kvn